ACADIA Pharmaceuticals Inc
F:DR6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
V
|
Vinci SA
XHAM:SQU
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DR6's stock price target?
Price Target
26.23
EUR
According to Wall Street analysts, the average 1-year price target for 
DR6 is 26.23 EUR with a low forecast of 12.27 EUR and a high forecast of 36.75 EUR.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%
The compound annual growth rate for Operating Income over the next 8 years is 27%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
33%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 33%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.